BRPI0720542A2 - Compostos antibacterianos e processos para a sua produção - Google Patents

Compostos antibacterianos e processos para a sua produção

Info

Publication number
BRPI0720542A2
BRPI0720542A2 BRPI0720542-2A2A BRPI0720542A BRPI0720542A2 BR PI0720542 A2 BRPI0720542 A2 BR PI0720542A2 BR PI0720542 A BRPI0720542 A BR PI0720542A BR PI0720542 A2 BRPI0720542 A2 BR PI0720542A2
Authority
BR
Brazil
Prior art keywords
processes
production
antibacterial compounds
compounds
antibacterial
Prior art date
Application number
BRPI0720542-2A2A
Other languages
English (en)
Inventor
Matthew J Lamarche
Jennifer A Leeds
Philipp Krastel
Hans-Ulrich Naegeli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0720542A2 publication Critical patent/BRPI0720542A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0720542-2A2A 2006-12-20 2007-12-19 Compostos antibacterianos e processos para a sua produção BRPI0720542A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87105106P 2006-12-20 2006-12-20
US88959107P 2007-02-13 2007-02-13
US89298807P 2007-03-05 2007-03-05
PCT/US2007/025955 WO2008082562A2 (en) 2006-12-20 2007-12-19 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production

Publications (1)

Publication Number Publication Date
BRPI0720542A2 true BRPI0720542A2 (pt) 2014-01-21

Family

ID=39166701

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0720542-2A2A BRPI0720542A2 (pt) 2006-12-20 2007-12-19 Compostos antibacterianos e processos para a sua produção

Country Status (15)

Country Link
US (1) US8183341B2 (pt)
EP (1) EP2097423B1 (pt)
JP (1) JP5230647B2 (pt)
KR (1) KR20090082504A (pt)
CN (1) CN101563353B (pt)
AT (1) ATE500259T1 (pt)
AU (1) AU2007339279A1 (pt)
BR (1) BRPI0720542A2 (pt)
CA (1) CA2673506A1 (pt)
DE (1) DE602007012935D1 (pt)
EA (1) EA200900816A1 (pt)
MX (1) MX2009006745A (pt)
PL (1) PL2097423T3 (pt)
PT (1) PT2097423E (pt)
WO (1) WO2008082562A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101202483B1 (ko) * 2007-06-04 2012-11-16 노파르티스 아게 거대고리 및 그의 용도
BRPI0821138A2 (pt) 2007-12-12 2015-06-16 Novatis Ag Aminotiazóis e seus usos
JP2011116662A (ja) * 2008-03-26 2011-06-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規抗生物質ｓｆ２８７６物質、その製造法および医薬組成物
WO2012144790A1 (en) 2011-04-18 2012-10-26 B&C Biopharm Co., Ltd. Cyclic peptide from nonomuraea sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
JP6273279B2 (ja) * 2012-08-14 2018-01-31 コーリア リサーチ インスティテュート オブ ケミカル テクノロジー ストレプトマイセス・スコプリリディスｋｒ−００１株またはその培養液を活性成分として含む雑草防除用組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740299A (en) * 1985-05-14 1988-04-26 Parker Hannifin Corporation Filter assembly with threaded collection bowl
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
DE69016284T2 (de) * 1989-07-04 1995-05-24 Lepetit Spa Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
ATE121459T1 (de) * 1990-03-08 1995-05-15 Lepetit Spa Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DK0529410T3 (da) * 1991-08-30 1998-05-11 Biosearch Italia Spa Antibiotikum GE 2270 faktor C2a
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
WO1994014838A1 (en) 1992-12-22 1994-07-07 Gruppo Lepetit S.P.A. Antibiotics ge 37468 a, b and c
US5547686A (en) 1994-08-15 1996-08-20 Clemson University Feed supplements for ruminants and method for using same
AU3805295A (en) 1994-11-08 1996-05-31 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d2
SI0808326T1 (en) * 1995-02-07 2001-12-31 Biosearch Italia Spa Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
JP2825667B2 (ja) * 1995-02-07 1998-11-18 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ Ｇｅ２２７０及びｇｅ２２７０−様抗生物質の塩基性プロリン−アミド誘導体
IL125107A (en) * 1996-02-14 2002-12-01 Biosearch Italia Spa Derivatives of antibiotics GE2270 factors D2, C2a and E, process for their preparation and pharmaceutical compounds containing them
DE10160497A1 (de) * 2001-12-08 2003-06-12 Mann & Hummel Filter Verfahren und Vorrichtung zum Speichern von aus Kraftstoff ausgefiltertem Wasser
ES2364269T3 (es) 2002-06-17 2011-08-30 Naicons S.C.A.R.L. Uso de derivado de amida de ge 2270 factor a3 para el tratamiento del acné.
EP1793812A4 (en) 2004-09-22 2009-08-26 Merck & Co Inc ANTIBIOTIC CONNECTION
PE20080103A1 (es) 2006-05-31 2008-04-03 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu

Also Published As

Publication number Publication date
EP2097423B1 (en) 2011-03-02
US20100093615A1 (en) 2010-04-15
CA2673506A1 (en) 2008-07-10
WO2008082562A2 (en) 2008-07-10
PT2097423E (pt) 2011-06-01
JP5230647B2 (ja) 2013-07-10
WO2008082562A3 (en) 2008-11-13
JP2010513512A (ja) 2010-04-30
US8183341B2 (en) 2012-05-22
MX2009006745A (es) 2009-08-19
EP2097423A2 (en) 2009-09-09
KR20090082504A (ko) 2009-07-30
PL2097423T3 (pl) 2011-07-29
EA200900816A1 (ru) 2009-12-30
CN101563353B (zh) 2012-06-27
AU2007339279A1 (en) 2008-07-10
DE602007012935D1 (de) 2011-04-14
ATE500259T1 (de) 2011-03-15
CN101563353A (zh) 2009-10-21

Similar Documents

Publication Publication Date Title
NL301256I2 (nl) cedazuridine, of een farmaceutisch aanvaardbaar zout daarvan
NL301202I2 (nl) Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline
IL282138A (en) Process for preparing purified drug conjugates
LTC2187879I2 (lt) Farmacinė kompozicija, apimanti gliukopiranozil-pakeistojo benzeno darinį
NL300886I2 (nl) baricitinib, of een farmaceutisch aanvaardbaar zout daarvan
BRPI0719843A2 (pt) Método para a produção de bisbenzoxazóis
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
FR2913421B1 (fr) Procede de fabrication de dichloropropanol.
BRPI0819238A2 (pt) Métodos para a produção de caseína
BRPI0810991A2 (pt) Método para a produção de um composto de amida.
CY1119121T1 (el) Αμορφο αλας ενος μακροκυκλικου αναστολεα του hcv
BRPI0821102A2 (pt) Preparação de derivados de di-hidropirrol como intermediários
ITBO20060719A1 (it) Macchina per la produzione di filtri composti.
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
BRPI0720542A2 (pt) Compostos antibacterianos e processos para a sua produção
BRPI0811140A2 (pt) processos melhorados para produção de hidrazidas
ITBO20060720A1 (it) Macchina per la produzione di filtri composti.
EP1874948A4 (en) PROCESS FOR THE PREPARATION OF Y-GLUTAMYLCYSTEIN
ZA200706067B (en) Production process for NSAID-containing lozenges, their compositions, their medicinal use
BRPI0819653A2 (pt) Método para a produção de um composto de tetrapirrol, e, composto de tetrapirrol.
BRPI0812814A2 (pt) Composição antiperspirante emulsionada e método para a produção da mesma.
WO2009069800A1 (ja) 新規アミノグリコシド抗生物質、その製造方法およびその医薬用途
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
BRPI0812812A2 (pt) Método para a produção de um produto antiperspirante emulsionado.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]